(Q46132994)

English

Safety and efficacy of the simultaneous administration of udenafil and an alpha-blocker in men with erectile dysfunction concomitant with BPH/LUTS.

scientific article published on 5 February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19194451

Safety and efficacy of the simultaneous administration of udenafil and an alpha-blocker in men with erectile dysfunction concomitant with BPH/LUTS. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19194451

erectile dysfunction

1 reference

based on heuristic

inferred from title

author name string

B H Chung

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19194451

J Y Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19194451

S H Lee

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19194451

S J Yoo

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19194451

S W Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19194451

C Y Oh

6

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19194451

publication date

5 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19194451

International Journal of Impotence Research

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19194451

21

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19194451

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19194451

122-128

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19194451

https://scigraph.springernature.com/pub.10.1038/ijir.2009.2

0 references

Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Erectile dysfunction (ED) is prevalent, bothersome and underdiagnosed in patients consulting urologists for benign prostatic syndrome (BPS).

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both?

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Lower urinary tract symptoms and sexual dysfunction: a common approach

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

EAU Guidelines on erectile dysfunction: an update

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up study to evaluate the efficacy and safety of the doxazosin gastrointestinal therapeutic system in patients with benign prostatic hyperplasia with or without concomitant hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of two doses (10 and 15 mg) of alfuzosin or tamsulosin (0.4 mg) once daily for treating symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacotherapy of erectile dysfunction: focus on cardiovascular safety

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of combination medical therapy in benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of alfuzosin and tadalafil exerts in vitro an additive relaxant effect on human corpus cavernosum

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

The association between lower urinary tract symptoms and sexual dysfunction: fact or fiction?

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of DA‐8159, a New Erectogenic, after Intravenous and Oral Administration to Rats: Hepatic and Intestinal First‐Pass Effects

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Alfuzosin: overview of pharmacokinetics, safety, and efficacy of a clinically uroselective alpha-blocker

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of tamsulosin for benign prostatic hyperplasia: clinical experience in the primary care setting

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Alfuzosin for symptomatic benign prostatic hyperplasia: long-term experience

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/IJIR.2009.2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19194451

Dimensions Publication ID

0 references

release_vdkvrbtnqneynky5cakfvnz7cy

1 reference

https://api.fatcat.wiki/v0/release/vdkvrbtnqneynky5cakfvnz7cy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19194451

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46132994&oldid=1837277965"